• 1
    Martin SR, Atkison P, Anand R et al. Studies of Pediatric Liver Transplantation 2002; Patient and graft-survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004; 8: 273283.
  • 2
    The SPLIT research group. Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. Transplantation 2001; 73: 463476.
  • 3
    Fridell JA, Jain A, Reyes J et al. Causes of mortality beyond 1 year after primary liver transplant under tacrolimus. Transplantation 2002; 74: 17211724.
  • 4
    Sudan D, Shaw BW, Langlans AN. Causes of late mortality in pediatric liver transplant recipients. Ann Surg 1998; 227: 289295.
  • 5
    Ryckmann FC, Alonso MH, Bucuvalas JC et al. Long-term survival after liver transplantation. J Pediatr Surg 1999; 34: 845850.
  • 6
    Sieders E, Peeters PMJ, TanVertgert EM et al. Graft loss after pediatric liver transplantation. Ann Surg 2002; 235: 125132.
  • 7
    Goss JA, Shackleton CR, McDiarmid SV et al. Long-term results of pediatric liver transplantation: An analysis of 569 transplants. Ann Surg 1998; 228: 411420.
  • 8
    Wallot MA, Mathot M, Janssen M et al. Long-term survival and late graft loss in pediatric liver transplant recipients: A 15 year single-center experience. Liver Transpl 2002; 8: 615625.
  • 9
    Jain A, Mazariegos G, Pokharna R et al. The absence of chronic rejection in pediatric liver transplant patients who are maintained on tacrolimus-based immunosuppression: A long term analysis. Transplantation 2003; 75: 10201025.
  • 10
    Cacciarelli TV, Dvorchik I, Mazariegos GV et al. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1999; 68: 650655.
  • 11
    Gupta P, Hart J, Cronin D et al. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001; 72: 10981102.
  • 12
    Cao S, Cox KL, Berquist W et al. Long-term outcomes in pediatric liver recipients: Comparison between cyclosporine A and tacrolimus. Pediatr Transplant 1999; 3: 2226.
  • 13
    Jain A, Reyes J, Kashyap R et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 4: 490500.
  • 14
    Abbasoglu O, Levy MF, Brkic BB et al. Ten years of liver transplantation: An evolving understanding of late graft loss. Transplantation 1997; 64: 18011807.
  • 15
    Shepard RW, Chin SE, Cleghorn GE. Malnutrition in children with chronic liver disease accepted for liver transplantation: Clinical profile and effect on outcome. J Paediatr Child Health 1991; 27: 295299.
  • 16
    Jain A, Mazariegos G, Kashyap R et al. Pediatric liver transplantation. Transplantation 2002; 73: 941947.
  • 17
    McDiarmid SV, Jordan S, Lee G et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998; 66: 16041611.
  • 18
    Rowe DT, Webber S, Schauer EM et al. Epstein-Barr virus load monitoring: Its role in the prevention and management of posttransplant lymphoproliferative disease. Transpl Inf Dis 2001; 3: 7987.
  • 19
    Balagia P, Alvarez S, Lindblad A et al. Posttransplant survival in pediatric fulminant hepatic failure: The SPLIT experience. Liver Transpl 2004; 10: 13641371.
  • 20
    Goss J, Shackleton C, Maggard M et al. Liver transplantation for fulminant hepatic failure in the pediatric patient. Arch Surg 1998; 133: 839844.
  • 21
    Squires RH Jr, Shneider BL, Bucuvalas J et al. Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148: 652658.